ExodusPoint Capital Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-71,503
| Closed | -$491K | – | 1689 |
|
|
2024
Q2 | $491K | Buy |
71,503
+51,180
| +252% | +$351K | ﹤0.01% | 1084 |
|
|
2024
Q1 | $196K | Buy |
+20,323
| New | +$196K | ﹤0.01% | 1236 |
|
|
2023
Q4 | – | Sell |
-453,898
| Closed | -$3.79M | – | 1657 |
|
|
2023
Q3 | $3.79M | Buy |
+453,898
| New | +$3.79M | 0.04% | 417 |
|
|
2023
Q2 | – | Sell |
-59,650
| Closed | -$820K | – | 1937 |
|
|
2023
Q1 | $820K | Buy |
59,650
+12,570
| +27% | +$173K | 0.01% | 1110 |
|
|
2022
Q4 | $801K | Buy |
47,080
+21,595
| +85% | +$367K | 0.01% | 992 |
|
|
2022
Q3 | $580K | Buy |
+25,485
| New | +$580K | 0.01% | 1283 |
|
|
2022
Q2 | – | Sell |
-10,728
| Closed | -$287K | – | 2092 |
|
|
2022
Q1 | $287K | Buy |
10,728
+1,698
| +19% | +$45.4K | ﹤0.01% | 1720 |
|
|
2021
Q4 | $265K | Buy |
9,030
+3,903
| +76% | +$115K | ﹤0.01% | 1672 |
|
|
2021
Q3 | $337K | Sell |
5,127
-1,666
| -25% | -$110K | ﹤0.01% | 1525 |
|
|
2021
Q2 | $565K | Buy |
6,793
+391
| +6% | +$32.5K | 0.01% | 1236 |
|
|
2021
Q1 | $491K | Buy |
+6,402
| New | +$491K | 0.01% | 1336 |
|
|
2020
Q4 | – | Sell |
-4,295
| Closed | -$317K | – | 2058 |
|
|
2020
Q3 | $317K | Buy |
+4,295
| New | +$317K | 0.01% | 1197 |
|
|
2020
Q2 | – | Sell |
-29,834
| Closed | -$1.68M | – | 1852 |
|
|
2020
Q1 | $1.68M | Buy |
+29,834
| New | +$1.68M | 0.09% | 179 |
|